Dia 2

Hay Lugar Aun Para los Inhibidores GPIIbIIIa?

Pedro Ureña Velásquez2014-08-08FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada   

Thromboprophylaxis with antiplatelet agents in patients with mechanical aortic valves

Raúl García-Rinaldo2014-08-08MD, PhD, FACS Ponce School of Medicine, Ponce, PRMayaguez Medical Center, Mayaguez, PR

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

Percutaneous Treatment of Mitral Regurgitation

Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

Evaluation and Management of Asymptomatic Aortic Stenosis

Augusto Pichard2014-08-08Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of...

TAVI: Present and Future Perspective

Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

Manejo Endovascular de los Síndromes Agudos de la aorta torácica

Jorge Mayol2014-08-08Servicio de Cardiología Intervencionista Centro Cardiológico Americano Montevideo - Uruguay